MetSense Pilot and Feasibility

Clinical trial NCT07264062 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT07264062
Sponsor: Kaiser Permanente
Status: ENROLLING_BY_INVITATION
Phase: Not Applicable
Study type: INTERVENTIONAL

Serious Mental Illness Type 2 Diabetes

Start date: 2025-12-01
Primary completion: 2026-12-31
Enrollment: 20000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.